Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-02-06 @ 6:52 PM
Study NCT ID:
NCT01854294
Status:
COMPLETED
Last Update Posted:
2021-04-27
First Post:
2013-05-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)
Sponsor:
Genervon Biopharmaceuticals, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08
Start Date Type:
None
Primary Completion Date:
2014-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-07
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-08
First Submit QC Date:
None
Study First Post Date:
2013-05-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-08-08
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-04-23
Last Update Post Date:
2021-04-27
Last Update Post Date Type:
ACTUAL